Chimerix (CMRX) Names RaNA Therapeutics CEO Renaud as Director
Tweet Send to a Friend
Chimerix (NASDAQ: CMRX) announced Ronald C. Renaud, Jr. has been appointed to Chimerix's Board of Directors. Mr. Renaud currently serves ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE